Floatz logo

DENTALFLUORO

Bone Metastases From Breast or Prostate Cancer

British Columbia Cancer AgencySmall moleculePhase 3Dormant
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Bone Metastases From Breast or Prostate Cancer cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

DENTALFLUORO is also rated in:

metastatic carcinoma in the boneDormant
BB
Indicative ·
66 / 100
View asset →
prostate neoplasmDormant
B
Indicative ·
57 / 100
View asset →
metastatic prostate carcinomaDormant
CCC
Indicative ·
55 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →